These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9770211)
41. Elevation of angiotensin converting enzyme in bovine endothelial cells quantitated by an ELISA. Dasarathy Y; Stevens J; Lanzillo JJ; Fanburg BL Life Sci; 1990; 47(10):883-9. PubMed ID: 1699104 [TBL] [Abstract][Full Text] [Related]
42. Inactivation of enkephalins: effect of purified peptidyl dipeptidase and cultured human endothelial cells. Erdös EG; Johnson AR; Boyden NT Adv Biochem Psychopharmacol; 1978; 18():45-9. PubMed ID: 206117 [No Abstract] [Full Text] [Related]
43. Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: effect of aspartic acid and naloxone. Koyuncuoğlu H; Güngör M; Enginar N; Hatipoğlu I; Hizal A Pharmacol Biochem Behav; 1986 Nov; 25(5):953-7. PubMed ID: 3024185 [TBL] [Abstract][Full Text] [Related]
44. Paraquat depresses the activity of angiotensin converting enzyme expressed by human umbilical vein endothelial cells in culture. Watanabe K; Tamaru N; Yoshida M Cell Biol Int Rep; 1991 Mar; 15(3):205-10. PubMed ID: 1851671 [TBL] [Abstract][Full Text] [Related]
45. Opiate structure and activity--a guide to understanding the receptor. Thorpe DH Anesth Analg; 1984 Feb; 63(2):143-51. PubMed ID: 6318606 [No Abstract] [Full Text] [Related]
46. Effect of morphine and naloxone on leu-enkephalin-like immunoreactivity in dogs. Laasberg LH; Johnson EE; Hedley-Whyte J J Pharmacol Exp Ther; 1980 Mar; 212(3):496-502. PubMed ID: 7359349 [No Abstract] [Full Text] [Related]
47. The effect of peptides on cerebrovascular resistance in cats. Wahl M Adv Exp Med Biol; 1985; 191():121-30. PubMed ID: 2870612 [No Abstract] [Full Text] [Related]
48. Effect of morphine on diuresis in normal and diabetes insipidus dogs. Montastruc JL; Morales-Olivas F; Montastruc P Arch Farmacol Toxicol; 1980 Dec; 6(3):287-90. PubMed ID: 6272657 [No Abstract] [Full Text] [Related]
49. Opiates and specific receptor binding of [3H]clonidine. Golembiowska-Nikitin K; Pilc A; Vetulani J J Pharm Pharmacol; 1980 Jan; 32(1):70-1. PubMed ID: 6102136 [No Abstract] [Full Text] [Related]
50. High enkephalyl peptide degradation, due to angiotensin-converting enzyme-like activity in human CSF. Lantz I; Terenius L FEBS Lett; 1985 Nov; 193(1):31-4. PubMed ID: 2998876 [TBL] [Abstract][Full Text] [Related]
51. The effects of morphine on cell proliferation. Glasel JA Prog Drug Res; 2000; 55():33-80. PubMed ID: 11127966 [TBL] [Abstract][Full Text] [Related]
52. Depression of atrium function by narcotics. Gintautas J; Kraynack BJ; Cockings E; Havasi G Proc West Pharmacol Soc; 1982; 25():55-6. PubMed ID: 7122540 [No Abstract] [Full Text] [Related]
53. Pharmacodynamics of opioids: recent developments. Folkers G; Michael M Pharm Acta Helv; 1994 Oct; 69(2):61-8. PubMed ID: 7809173 [TBL] [Abstract][Full Text] [Related]
54. The ideal epidural opioid--fact or fantasy? Chrubasik J; Chrubasik S; Martin E Eur J Anaesthesiol; 1993 Mar; 10(2):79-100. PubMed ID: 8385005 [No Abstract] [Full Text] [Related]
55. [Pharmacology of morphine and morphinomimetics]. Andréjak M; Schmitt H Rev Prat; 1983 Feb; 33(7):279-80 passim. PubMed ID: 6844828 [No Abstract] [Full Text] [Related]